As of 2026-03-17, the Relative Valuation of Collegium Pharmaceutical Inc (COLL) is 45.31 USD. This relative valuation is based on P/E multiples. With the latest stock price at 35.62 USD, the upside of Collegium Pharmaceutical Inc based on Relative Valuation is 27.2%.
The range of the Relative Valuation is 35.01 - 54.89 USD.
| Range | Selected | |
| Trailing P/E multiples | 19.0x - 20.9x | 19.5x |
| Forward P/E multiples | 18.5x - 20.0x | 19.9x |
| Fair Price | 35.01 - 54.89 | 45.31 |
| Upside | -1.7% - 54.1% | 27.2% |
| Date | P/E |
| 2026-03-16 | 19.35 |
| 2026-03-13 | 18.74 |
| 2026-03-12 | 19.01 |
| 2026-03-11 | 19.35 |
| 2026-03-10 | 19.89 |
| 2026-03-09 | 20.25 |
| 2026-03-06 | 20.26 |
| 2026-03-05 | 20.25 |
| 2026-03-04 | 21.52 |
| 2026-03-03 | 21.73 |
| 2026-03-02 | 22.60 |
| 2026-02-27 | 22.64 |
| 2026-02-26 | 24.02 |
| 2026-02-25 | 24.85 |
| 2026-02-24 | 24.54 |
| 2026-02-23 | 24.37 |
| 2026-02-20 | 24.45 |
| 2026-02-19 | 24.54 |
| 2026-02-18 | 24.60 |
| 2026-02-17 | 25.04 |
| 2026-02-13 | 24.88 |
| 2026-02-12 | 24.60 |
| 2026-02-11 | 24.52 |
| 2026-02-10 | 25.40 |
| 2026-02-09 | 25.14 |
| 2026-02-06 | 25.86 |
| 2026-02-05 | 25.49 |
| 2026-02-04 | 26.17 |
| 2026-02-03 | 25.81 |
| 2026-02-02 | 25.59 |
| 2026-01-30 | 24.95 |
| 2026-01-29 | 24.64 |
| 2026-01-28 | 24.35 |
| 2026-01-27 | 24.62 |
| 2026-01-26 | 24.89 |
| 2026-01-23 | 24.72 |
| 2026-01-22 | 25.59 |
| 2026-01-21 | 25.54 |
| 2026-01-20 | 25.91 |
| 2026-01-16 | 24.77 |
| 2026-01-15 | 25.48 |
| 2026-01-14 | 25.30 |
| 2026-01-13 | 25.69 |
| 2026-01-12 | 26.16 |
| 2026-01-09 | 24.74 |
| 2026-01-08 | 26.50 |
| 2026-01-07 | 25.67 |
| 2026-01-06 | 25.10 |
| 2026-01-05 | 24.82 |
| 2026-01-02 | 24.73 |